搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
11 天
Seven major symptoms of deadly cancer with 5% survival rate that are often missed
Pancreatic cancer has a notoriously low survival rate, with just 5% of patients living 10 or more years after diagnosis - ...
10 天
on MSN
High survival rates explain 20 years of rapid expansion of wolves in Germany
Since wolves returned to Germany 20 years ago, they have spread quickly in many parts of the country. The rapid increase was ...
emjreviews.com
2 天
No Survival Benefit of Extended Lymphadenectomy in Bladder Cancer Surgery
A recent study reveals that extended lymphadenectomy offers no survival advantage over standard lymphadenectomy for patients ...
9 天
Urgent action needed to improve survival rate of people with rare cancers, campaigners say
People with rare cancers often have to battle for months or years before they are diagnosed with the disease, and the late ...
The Shetland Times
12 天
Salmon survival rates at highest since pandemic began
Scottish salmon has recorded its best survival rate since the pandemic. This was the assessment of Salmon Scotland chief ...
Science Daily
11 天
High survival rates explain 20 years of rapid expansion of wolves in Germany
The rapid increase in the number of wolves was due to high survival and reproduction rates in areas with favorable environmental conditions. Since wolves returned to Germany 20 years ago ...
4 天
on MSN
Cachexia decoded: Why diagnosis matters in cancer survival
Maintaining good health and well-being is crucial for how well patients respond to cancer treatments. Unfortunately, cachexia ...
Cure Today
4 天
Chemo-Radiotherapy Combo May Improve Survival in Advanced Cervical Cancer
Induction chemotherapy shows significant improvements for survival in patients with locally advanced cervical cancer.
Medscape
6 天
Pembrolizumab Boosts Survival in Anaplastic Thyroid Cancer
With a median follow-up of 21 months, the progression-free survival was not reached in the pembrolizumab group and was 5.4 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈